Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 145Colorectal Neoplasms 97Carcinoma, Non-Small-Cell Lung 97Carcinoma, Hepatocellular 69Stomach Neoplasms 65Rectal Neoplasms 54Neoplasms 53Lung Neoplasms 44Prostatic Neoplasms 41Colonic Neoplasms 41Leukemia, Myeloid, Acute 40Nasopharyngeal Carcinoma 39Lymphoma, Large B-Cell, Diffuse 39Uterine Cervical Neoplasms 37Neoplasm Metastasis 33Esophageal Neoplasms 33Ovarian Neoplasms 32Multiple Myeloma 31Lymphoma 31Lymphoma, Follicular 30Leukemia 28Pancreatic Neoplasms 27Recurrence 23Head and Neck Neoplasms 22Brain Neoplasms 21Urinary Bladder Neoplasms 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Lymphoma, Non-Hodgkin 19Lymphoma, Mantle-Cell 18Squamous Cell Carcinoma of Head and Neck 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Joint Diseases × Clear all
NCT04842071 2024-02-07

18F-sodium Fluoride (NaF) PET to Replace Bone Scintigraphy: Safety and Efficacy Assessment

Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Phase 3 Unknown
2,500 enrolled
Sarcoma

Bone Diseases, Bone Neoplasms, Communicable Diseases, Joint Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡